Edwyn
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3,197 | $3,578 | $4,223 | $4,685 | $5,146 |
| Gross Profit | $1,839 | $2,024 | $2,356 | $2,655 | $3,055 |
| Operating Income | $904 | $1,000 | $1,132 | $1,320 | $1,685 |
| Net Income | $475 | $779 | $898 | $1,021 | $1,401 |
Over the past five years, ResMed Inc. has demonstrated consistent financial growth across all key metrics. Revenue increased from approximately $3.20 billion in 2021 to about $5.15 billion in 2025, representing a compounded annual growth rate in the mid-single digits. Gross profit followed a similar upward trend, rising from $1.84 billion to $3.05 billion over the same period, which suggests the company has maintained favorable margins despite potential cost pressures. Operating income grew from roughly $0.90 billion to $1.69 billion, and net income increased significantly from $0.47 billion to $1.40 billion. Notably, the jump in net income from 2021 to 2022 was substantial—an increase of around 64%—indicating a possible year-over-year improvement in operational efficiency or a reduction in costs relative to revenue. Additionally, a robust increase in net income of nearly 37% from 2024 to 2025 highlights the company's capacity to translate revenue growth into bottom-line expansion. This steady climb in financial performance is particularly relevant within the medtech industry, where innovative respiratory care solutions drive competitive advantages and market share expansion. ResMed’s ability to enhance both operating and net income amid rising revenues signals sound operational practices and effective cost management. Overall, the financial results reveal a company with healthy profitability and expanding margins, positioning ResMed Inc. as both financially robust and sustainable in the long term, reflecting the company's strategic focus in a competitive and evolving healthcare market.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.